Literature DB >> 22526675

Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit gamma interferon-mediated cellular activation.

Nathan K Ho1, Juan C Ossa, Uma Silphaduang, Roger Johnson, Kathene C Johnson-Henry, Philip M Sherman.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) serotype O157:H7 is a food-borne pathogen that causes significant morbidity and mortality in developing and industrialized nations. EHEC infection of host epithelial cells is capable of inhibiting the gamma interferon (IFN-γ) proinflammatory pathway through the inhibition of Stat-1 phosphorylation, which is important for host defense against microbial pathogens. The aim of this study was to determine the bacterial factors involved in the inhibition of Stat-1 tyrosine phosphorylation. Human HEp-2 and Caco-2 epithelial cells were challenged directly with either EHEC or bacterial culture supernatants and stimulated with IFN-γ, and then the protein extracts were analyzed by immunoblotting. The data showed that IFN-γ-mediated Stat-1 tyrosine phosphorylation was inhibited by EHEC secreted proteins. Using two-dimensional difference gel electrophoresis, EHEC Shiga toxins were identified as candidate inhibitory factors. EHEC Shiga toxin mutants were then generated and complemented in trans, and mutant culture supernatant was supplemented with purified Stx to confirm their ability to subvert IFN-γ-mediated cell activation. We conclude that while other factors are likely involved in the suppression of IFN-γ-mediated Stat-1 tyrosine phosphorylation, E. coli-derived Shiga toxins represent a novel mechanism by which EHEC evades the host immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526675      PMCID: PMC3416474          DOI: 10.1128/IAI.00255-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

Review 2.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

3.  Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19.

Authors:  A Huang; S de Grandis; J Friesen; M Karmali; M Petric; R Congi; J L Brunton
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

4.  Role of bacterial intimin in colonic hyperplasia and inflammation.

Authors:  L M Higgins; G Frankel; I Connerton; N S Gonçalves; G Dougan; T T MacDonald
Journal:  Science       Date:  1999-07-23       Impact factor: 47.728

5.  Enteric pathogens and gut function: Role of cytokines and STATs.

Authors:  Terez Shea-Donohue; Alessio Fasano; Allen Smith; Aiping Zhao
Journal:  Gut Microbes       Date:  2010-05-12

6.  Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

Authors:  Stéphanie Dupuis; Emmanuelle Jouanguy; Sami Al-Hajjar; Claire Fieschi; Ibrahim Zaid Al-Mohsen; Suliman Al-Jumaah; Kun Yang; Ariane Chapgier; Céline Eidenschenk; Pierre Eid; Abdulaziz Al Ghonaium; Haysam Tufenkeji; Husn Frayha; Suleiman Al-Gazlan; Hassan Al-Rayes; Robert D Schreiber; Ion Gresser; Jean-Laurent Casanova
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

7.  Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains.

Authors:  Kim Ziebell; Marina Steele; Yongxiang Zhang; Andrew Benson; Eduardo N Taboada; Chad Laing; Scott McEwen; Bruce Ciebin; Roger Johnson; Victor Gannon
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

8.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

9.  Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models.

Authors:  Lilach Golan; Erez Gonen; Simcha Yagel; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Dis Model Mech       Date:  2010-10-19       Impact factor: 5.758

10.  Identifying mechanisms by which Escherichia coli O157:H7 subverts interferon-γ mediated signal transducer and activator of transcription-1 activation.

Authors:  Nathan K Ho; Ian Crandall; Philip M Sherman
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more
  9 in total

1.  Host inflammatory response inhibits Escherichia coli O157:H7 adhesion to gut epithelium through augmentation of mucin expression.

Authors:  Yansong Xue; Hanying Zhang; Hui Wang; Jia Hu; Min Du; Mei-Jun Zhu
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

Review 2.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 3.  Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection.

Authors:  Nathan K Ho; Aleah C Henry; Kathene Johnson-Henry; Philip M Sherman
Journal:  Can J Gastroenterol       Date:  2013       Impact factor: 3.522

4.  Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence.

Authors:  Qiong Pan; Yin Tian; Xiaohuan Li; Jun Ye; Yun Liu; Lili Song; Yongtao Yang; Rong Zhu; Yonghong He; Lei Chen; Wensheng Chen; Xuhu Mao; Zhihong Peng; Rongquan Wang
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

5.  Identifying mechanisms by which Escherichia coli O157:H7 subverts interferon-γ mediated signal transducer and activator of transcription-1 activation.

Authors:  Nathan K Ho; Ian Crandall; Philip M Sherman
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

6.  Enterohemorrhagic Escherichia coli infection inhibits colonic thiamin pyrophosphate uptake via transcriptional mechanism.

Authors:  Kasin Yadunandam Anandam; Subrata Sabui; Morgan M Thompson; Sreya Subramanian; Hamid M Said
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

7.  Shiga toxin remodels the intestinal epithelial transcriptional response to Enterohemorrhagic Escherichia coli.

Authors:  Alyson R Warr; Carole J Kuehl; Matthew K Waldor
Journal:  PLoS Pathog       Date:  2021-02-02       Impact factor: 6.823

8.  Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coli O157:H7.

Authors:  Roberto Riquelme-Neira; Alejandra Rivera; Darwin Sáez; Pablo Fernández; Gonzalo Osorio; Felipe del Canto; Juan C Salazar; Roberto M Vidal; Angel Oñate
Journal:  Front Cell Infect Microbiol       Date:  2016-01-20       Impact factor: 5.293

9.  Protozoan Predation of Escherichia coli O157:H7 Is Unaffected by the Carriage of Shiga Toxin-Encoding Bacteriophages.

Authors:  Carrie E Schmidt; Smriti Shringi; Thomas E Besser
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.